| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2022053541-A1 | Compounds for use as appetite suppressant | 2020-09-10 |
| WO-2021263278-A1 | Rev-erb agonists for the treatment of th17-mediated inflammatory disorders | 2020-06-23 |
| WO-2021226206-A2 | Cannabinoid receptor type 2 (cb2) modulators and uses thereof | 2020-05-05 |
| WO-2021222363-A1 | Cycloalkyl pyrimidines as ferroportin inhibitors | 2020-04-28 |
| WO-2021222483-A1 | Methods of use for pyrimidines as ferroportin inhibitors | 2020-04-28 |
| WO-2021195781-A1 | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use | 2020-04-01 |
| WO-2021195782-A1 | Methods of using myt1 inhibitors | 2020-04-01 |
| WO-2021178488-A1 | Eif4e inhibitors and uses thereof | 2020-03-03 |
| WO-2021117846-A1 | Compound serving as pdgf receptor kinase inhibitor, and composition | 2019-12-13 |
| TW-202136234-A | Compounds and compositions as inhibitors of PDGF receptor kinase | 2019-12-13 |
